首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1561060

填充飾面製造市場規模、佔有率、成長分析、按產品、按最終用戶、按地區 - 行業預測，2024-2031 年

Fill Finish Manufacturing Market Size, Share, Growth Analysis, By Product (Consumables, Instruments), By End User (Contract Manufacturing Organizations, Pharmaceutical & Biopharmaceutical Companies), By Region - Industry Forecast 2024-2031

出版日期: 2024年09月19日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球填充塗料製造市場規模為1,65億美元，從2023年的179.5億美元成長到2031年的352.5億美元，預計複合年成長率為8.80%。

由於生物製藥需求的增加、慢性病的流行以及藥物輸送系統的進步，全球填充塗料製造市場正在穩步成長。人口老化和對個人化醫療的日益關注等關鍵因素進一步增加了對填充製造服務的需求。管瓶、注射器、藥筒和安瓿等消耗品佔據了重要的市場佔有率，其中預填充式注射器和創新包裝解決方案廣受歡迎。同時，灌裝機、封蓋機和檢查機等設備隨著技術進步而不斷發展，提高了製程自動化、效率和準確性，同時減少了污染風險和人為錯誤。

市場概況
消耗品
- 管瓶
- 管瓶
- 塑膠管瓶
- 管瓶瓶塞
- 預填充式注射器
- 按成分
- 預填充式注射器系統和組件
- 柱塞塞
- 按材質
- 玻璃預灌封預填充式注射器
- 塑膠預灌封預填充式注射器
- 墨水匣
- 其他消耗品
裝置
- 依系統類型
- 綜合系統
- 獨立系統
- 按機器類型
- 自動化機械
- 半自動和手動機器

填充飾面製造市場：依最終用戶分類

市場概況
契約製造組織
製藥和生物製藥公司
其他最終用戶

填充飾面製造市場規模：按地區

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市集活動
主要企業市場佔有率（2023年）

主要企業簡介

IMASPA（Italy）
BD（Becton, Dickinson and Company）（US）
West Pharmaceutical Services, Inc.（US）
Gerresheimer AG（Germany）
AptarGroup, Inc.（US）
Datwyler Holding Inc.（Switzerland）
Berry Global, Inc.（US）
tevanato Group SPA（Italy）
Optima（Germany）
Bausch+Strobel（Germany）
Groninger & Co. GmbH（Germany）
SGD Pharma（France）
Schott（Germany）
Nipro Corporation（Japan）
Bausch Advanced Technology Group（US）
Maquinaria Industrial Dara, SL（Spain）
Steriline SRL（Italy）
Automated Systems of Tacoma, LLC（US）
SiO2 Materials Science（US）
Weiler Engineering, Inc.（US）
Fedegari Autoclavi SPA（Italy）
DWK Life Sciences（Germany）
Rochling SE & Co. KG（Germany）
Terumo Corporation（Japan）
Pacific Vial Manufacturing Inc.（US）
SP Industries（US）

簡介目錄

Product Code: SQMIG35H2229

Global Fill Finish Manufacturing Market size was valued at USD 16.5 billion in 2022 and is poised to grow from USD 17.95 billion in 2023 to USD 35.25 billion by 2031, growing at a CAGR of 8.80% during the forecast period (2024-2031).

The global fill finish manufacturing market is witnessing steady growth, driven by the rising demand for biopharmaceuticals, the growing prevalence of chronic diseases, and advancements in drug delivery systems. Key factors such as the aging population and increasing focus on personalized medicine further fuel the demand for fill finish manufacturing services. Consumables, including vials, syringes, cartridges, and ampoules, hold a substantial market share, with prefilled syringes and innovative packaging solutions gaining significant traction. Meanwhile, instruments like filling, capping, and inspection machines are evolving with technological advancements, enhancing process automation, efficiency, and accuracy while reducing contamination risks and human error.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Fill Finish Manufacturing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Fill Finish Manufacturing Market Segmental Analysis

Global Fill Finish Manufacturing Market is segmented by Product, End User, and region. Based on Product, the market is segmented into Consumables, Instruments. Based on End User, the market is segmented into Contract Manufacturing Organizations, Pharmaceutical & Biopharmaceutical Companies, Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Drivers of the Global Fill Finish Manufacturing Market

The expanding biotechnology sector, driven by the development of innovative and personalized medicines, is emerging as a key driver for the global fill finish manufacturing market. As biopharmaceutical companies increasingly focus on producing complex and sensitive biologic products, there is a growing demand for advanced fill finish processes to ensure the safe and effective packaging, storage, and delivery of these high-value drugs. The sector's emphasis on precision and sterility, particularly for biologics like monoclonal antibodies, vaccines, and cell and gene therapies, is creating significant growth opportunities. Moreover, the rise in biologic-based treatments and the growing prevalence of chronic diseases are further fueling the need for sophisticated fill finish technologies to meet the stringent regulatory requirements for product safety and efficacy.

Restraints in the Global Fill Finish Manufacturing Market

Ensuring product integrity and preventing contamination during the fill finish process is crucial in pharmaceutical manufacturing. Any contamination or quality issues can lead to serious consequences, such as product recalls and harm to a company's reputation, emphasizing the need for rigorous quality control. This creates significant challenges for the fill finish manufacturing market, as it must implement effective strategies to minimize the risk of contamination. The industry's focus on maintaining high standards is essential to safeguarding product quality and protecting the reputation of pharmaceutical brands.

Market Trends of the Global Fill Finish Manufacturing Market

A notable trend in the global fill finish manufacturing market is the growing adoption of advanced technologies and automation. Fill finish manufacturing, which involves the final steps of pharmaceutical production-filling drug products into vials, syringes, or containers, followed by sealing and labeling-has seen a technological transformation in recent years. The shift towards automated systems and cutting-edge technologies is driven by the need to enhance efficiency, accuracy, and regulatory compliance. By integrating automation, companies can streamline the fill finish process, reducing errors and improving overall productivity, marking a significant evolution in the industry.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Value Chain Analysis
Supply Chain Analysis
Technology Analysis
Patent Analysis
Pricing Analysis
Regulatory Landscape
Customer & Buying Criteria Analysis

Fill Finish Manufacturing Market by Product

Market Overview
Consumables
- Vials
- Glass Vials
- Plastic Vials
- Vial Stoppers
- Pre-Fillable Syringes
- By Component
- Pre-Fillable Syringe Systems & Components
- Plunger Stoppers
- By Material
- Glass Pre-Fillable Syringes
- Plastic Pre-Fillable Syringes
- Cartridges
- Other Consumables
Instruments
- By System Type
- Integrated Systems
- Standalone Systems
- By Machine Type
- Automated Machines
- Semi-Automated & Manual Machines

Fill Finish Manufacturing Market by End User

Market Overview
Contract Manufacturing Organizations
Pharmaceutical & Biopharmaceutical Companies
Other End Users

Fill Finish Manufacturing Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

I.M.A. S.P.A. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BD (Becton, Dickinson and Company) (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
West Pharmaceutical Services, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Gerresheimer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AptarGroup, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Datwyler Holding Inc. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Berry Global, Inc. (US)
- S Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
tevanato Group S.P.A. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Optima (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bausch+Strobel (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Groninger & Co. GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SGD Pharma (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Schott (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nipro Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bausch Advanced Technology Group (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Maquinaria Industrial Dara, SL (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Steriline S.R.L. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Automated Systems of Tacoma, LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SiO2 Materials Science (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Weiler Engineering, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fedegari Autoclavi S.P.A. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DWK Life Sciences (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Rochling SE & Co. KG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pacific Vial Manufacturing Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SP Industries (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments